Co-Fineria

Co-Fineria combines Metformin Hydrochloride and Sitagliptin for oral use, aiding in blood sugar management. This medication is designed to support individuals with type 2 diabetes.

Co-Fineria is primarily used to help manage blood sugar levels in adults with type 2 diabetes. The combination of Metformin Hydrochloride and Sitagliptin works to improve glycemic control. This medication is often prescribed as part of a broader treatment plan that includes diet and exercise.

Common effects of Co-Fineria may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headache or dizziness. These effects are generally mild and temporary.

Co-Fineria should be handled with care, especially by individuals with kidney or liver issues. It is important to follow the advice of a healthcare provider regarding its use. Always store the medication in a cool, dry place away from direct sunlight.

Co-Fineria may interact with certain medications, including those that affect kidney function or blood sugar levels. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.